Healthpeak Q1 2022 Earnings Report
Key Takeaways
Healthpeak Properties reported first quarter 2022 results, with a net income of $0.13 per share and FFO as Adjusted of $0.43 per share. The company experienced a blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 5.6%.
Net income of $0.13 per share, Nareit FFO of $0.45 per share, FFO as Adjusted of $0.43 per share, and blended Total Same-Store Portfolio Cash (Adjusted) NOI growth of 5.6%.
Life Science and MOB Same-Store Portfolio Cash (Adjusted) NOI growth of 5.2% and 3.6%, respectively
Total pro forma Same-Store Portfolio Cash (Adjusted) NOI growth of 3.2% excluding government grants received under the CARES Act at CCRC properties.
Net debt to adjusted EBITDAre and liquidity were 5.1x and $2.1 billion, respectively, as of March 31, 2022
Healthpeak
Healthpeak
Forward Guidance
The company is reaffirming the following guidance ranges for full year 2022: Diluted earnings per common share of $0.58 – $0.64, Diluted Nareit FFO per share of $1.70 – $1.76, Diluted FFO as Adjusted per share of $1.68 – $1.74, Total Portfolio Same-Store Cash (Adjusted) NOI growth of 3.25% – 4.75%
Positive Outlook
- Diluted earnings per common share of $0.58 – $0.64
- Diluted Nareit FFO per share of $1.70 – $1.76
- Diluted FFO as Adjusted per share of $1.68 – $1.74
- Total Portfolio Same-Store Cash (Adjusted) NOI growth of 3.25% – 4.75%